系统性硬化相关间质性肺病死亡风险预测:SADL模型
研究基于两个纵向队列( derivation队列135例,validation队列90例)开发并验证Scl-ILD死亡风险预测模型。最终模型(SADL)包含吸烟史、年龄和DLCO占预计值百分比三个变量,连续模型在derivation队列C-index为0.88、validation队列为0.84,合并队列C-index为0.82,可区分3年低、中、高死亡风险。
要点
- SADL模型仅用吸烟史、年龄和DLCO占预计值百分比三个易获取变量预测全因死亡。
- 连续模型在derivation队列C-index 0.88,validation队列C-index 0.84,合并队列C-index 0.82。
- 基于合并队列建立评分系统,可划分3年低、中、高死亡风险。
核心结论
- SADL模型使用简单、易获取的临床变量预测Scl-ILD患者全因死亡风险。
研究设计与样本
- 研究基于两个正在进行的纵向队列:加州大学旧金山分校135例患者为derivation队列,Mayo Clinic 90例患者为validation队列。
- 共评估19个临床预测因子,测试所有包含3或4个变量的Cox模型以预测死亡时间,用C-index评估模型区分度。
主要发现
- 最终SADL模型包含三个变量:曾吸烟史、年龄、DLCO占预计值百分比。
- 连续模型在derivation队列C-index为0.88,validation队列C-index为0.84。
- 基于合并队列建立评分系统,C-index为0.82,可识别3年低、中、高死亡风险分类。
关键数值与推荐
- SADL模型变量:曾吸烟史、年龄、DLCO占预计值百分比。
- derivation队列C-index 0.88,validation队列C-index 0.84,合并队列C-index 0.82。
- 评分系统可划分3年低、中、高死亡风险。
临床怎么用
- 临床可用SADL模型中的吸烟史、年龄和DLCO占预计值百分比三个变量对Scl-ILD患者进行死亡风险分层。
- 评分系统有助于识别3年低、中、高死亡风险患者,辅助临床决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Interstitial lung disease (ILD) is an important cause of morbidity and mortality in patients with scleroderma (Scl). Risk prediction and prognostication in patients with Scl-ILD are challenging because of heterogeneity in the disease course. METHODS: We aimed to develop a clinical mortality risk prediction model for Scl-ILD. Patients with Scl-ILD were identified from two ongoing longitudinal cohorts: 135 patients at the University of California, San Francisco (derivation cohort) and 90 patients at the Mayo Clinic (validation cohort). Using these two separate cohorts, a mortality risk prediction model was developed and validated by testing every potential candidate Cox model, each including three or four variables of a possible 19 clinical predictors, for time to death. Model discrimination was assessed using the C-index. RESULTS: Three variables were included in the final risk prediction model (SADL): ever smoking history, age, and diffusing capacity of the lung for carbon monoxide (% predicted). This continuous model had similar performance in the derivation (C-index, 0.88) and validation (C-index, 0.84) cohorts. We created a point scoring system using the combined cohort (C-index, 0.82) and used it to identify a classification with low, moderate, and high mortality risk at 3 years. CONCLUSIONS: The SADL model uses simple, readily accessible clinical variables to predict all-cause mortality in Scl-ILD.
引用
- Morisset J, Vittinghoff E, Elicker BM, et al. Mortality Risk Prediction in Scleroderma-Related Interstitial Lung Disease: The SADL Model. Chest. 2017. PMID: 28629914. doi:10.1016/j.chest.2017.06.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。